Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 1 |
2014 | 1 |
2015 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.
N Engl J Med. 2014.
PMID: 24450891
Free PMC article.
Clinical Trial.
Invertible promoters mediate bacterial phase variation, antibiotic resistance, and host adaptation in the gut.
Jiang X, Hall AB, Arthur TD, Plichta DR, Covington CT, Poyet M, Crothers J, Moses PL, Tolonen AC, Vlamakis H, Alm EJ, Xavier RJ.
Jiang X, et al.
Science. 2019 Jan 11;363(6423):181-187. doi: 10.1126/science.aau5238.
Science. 2019.
PMID: 30630933
Free PMC article.
Item in Clipboard
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Wootla B, Denic A, Watzlawik JO, Warrington AE, Rodriguez M.
Wootla B, et al.
J Neuroinflammation. 2015 Apr 29;12:83. doi: 10.1186/s12974-015-0303-y.
J Neuroinflammation. 2015.
PMID: 25924771
Free PMC article.
We previously showed that as the disease progresses, a marked decrease in brainstem N-acetyl aspartate (NAA; metabolite associated with neuronal integrity) concentrations, reflecting axon health, is measured. ...
We previously showed that as the disease progresses, a marked decrease in brainstem N-acetyl aspartate (NAA; metabolite associated wi …
Item in Clipboard
A Cross-Cutting Approach to Surveillance and Laboratory Capacity as a Platform to Improve Health Security in Uganda.
Lamorde M, Mpimbaza A, Walwema R, Kamya M, Kapisi J, Kajumbula H, Sserwanga A, Namuganga JF, Kusemererwa A, Tasimwa H, Makumbi I, Kayiwa J, Lutwama J, Behumbiize P, Tagoola A, Nanteza JF, Aniku G, Workneh M, Manabe Y, Borchert JN, Brown V, Appiah GD, Mintz ED, Homsy J, Odongo GS, Ransom RL, Freeman MM, Stoddard RA, Galloway R, Mikoleit M, Kato C, Rosenberg R, Mossel EC, Mead PS, Kugeler KJ.
Lamorde M, et al.
Health Secur. 2018 Fall;16(S1):S76-S86. doi: 10.1089/hs.2018.0051.
Health Secur. 2018.
PMID: 30480504
Item in Clipboard
A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
Kittles RA, Baffoe-Bonnie AB, Moses TY, Robbins CM, Ahaghotu C, Huusko P, Pettaway C, Vijayakumar S, Bennett J, Hoke G, Mason T, Weinrich S, Trent JM, Collins FS, Mousses S, Bailey-Wilson J, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD.
Kittles RA, et al.
J Med Genet. 2006 Jun;43(6):507-11. doi: 10.1136/jmg.2005.035790. Epub 2005 Sep 9.
J Med Genet. 2006.
PMID: 16155194
Free PMC article.
Item in Clipboard
Cite
Cite